Can Exercise Ease 'Chemobrain' During Chemotherapy?
In a groundbreaking study, researchers have discovered that simple exercises during chemotherapy may significantly reduce treatment-related cognitive impairment, offering hope to cancer patients facing 'chemo brain'.
The study, published in the Journal of the National Comprehensive Cancer Network (NCCN), found that a structured and individualized exercise program combining walking and resistance band training significantly reduced cognitive impairment and mental fatigue compared to usual care. This is a major breakthrough, as up to three-quarters of patients experience cancer-related cognitive impairment during treatment, often accompanied by mental fatigue.
Dr. Karen Mustian, a key researcher, emphasizes the potential impact of these findings. "Cancer care providers should consider incorporating structured, home-based exercise programs into routine chemotherapy care." This recommendation is further supported by the NCCN, which already suggests that cancer survivors with cognitive dysfunction engage in regular physical activity.
The study enrolled 687 chemotherapy-naive adults with various cancers and no physical limitations. Participants were randomly assigned to either the Exercise for Cancer Patients (EXCAP) intervention or usual care. EXCAP is a 6-week program tailored to individual needs, combining walking and resistance band exercises, introduced during a single training session and reinforced through follow-up calls.
The results were remarkable. Patients in the EXCAP group maintained their activity levels, while those in the usual care group reduced their daily steps by half. The exercise group also added resistance-band training three times a week, significantly improving cognitive function and reducing mental fatigue.
The study's strength lies in its focus on the impact of different chemotherapy schedules. Patients receiving chemotherapy every 2 weeks showed the most significant benefits, with reduced cognitive impairment and mental fatigue. This finding suggests that the timing of chemotherapy cycles may influence the effectiveness of exercise interventions.
Dr. Mustian speculates that 2-week cycles may result in less severe acute side effects, allowing patients to remain more active. In contrast, 3-week cycles may lead to more severe side effects, hindering physical activity. This highlights the importance of considering individual chemotherapy schedules when designing exercise programs.
The study also explored the relationship between exercise, cognitive impairment, and inflammation. It found that a 'healthy inflammatory response' was associated with better cognitive outcomes, suggesting that immune regulation plays a role in chemotherapy-related cognitive symptoms. Exercise may help maintain normal inflammatory and immune responses, thereby reducing cognitive impairment.
The potential role of exercise oncology specialists is significant. With over 2000 programs across the US, these specialists can tailor exercise programs for individual capabilities. Oncologists can refer patients to these specialists, providing access to qualified professionals and credible exercise resources.
The implications of this study are far-reaching. Maintaining cognitive function during treatment is crucial for patients' independence, work, and overall quality of life. Structured physical activity, such as the EXCAP program, offers a low-cost and accessible intervention to support long-term survivorship and cognitive resilience.
In conclusion, this study provides compelling evidence that exercise can be a powerful tool to combat 'chemo brain'. By incorporating exercise into chemotherapy care, healthcare providers can help patients maintain their cognitive abilities and overall well-being during a challenging treatment journey.
